Urška Kamenšek

1.2k citations
52 papers · 841 indexed · h-index 17
Topics
Microbial Inactivation Methods (35 papers)Virus-based gene therapy research (12 papers)Microfluidic and Bio-sensing Technologies (12 papers)

In The Last Decade

Urška Kamenšek

50 papers receiving 830 citations

Peers

Urška Kamenšek
Comparison fields: 5 of 73
  • Biotechnology 557
  • Molecular Biology 370
  • Biomedical Engineering 252
  • Immunology 243
  • Oncology 135
Replace P. Urbas with:
P. Urbas United States
Urša Lampreht Tratar Slovenia
Tanja Dolinšek Slovenia
Darja Pavlin Slovenia
Mehmet Kemal Tur Germany
Marco Schmeer Germany
C. Calvet France
Michael J. Gramer United States
Eonju Oh South Korea
Peter Kulmburg Germany
Urška Kamenšek relative to P. Urbas United States P. Urbas's profile →
Citations per field
00.5×4.1×
P. Urbas · 1×
Citations per year

Countries citing papers authored by Urška Kamenšek

Since Specialization
Citations

This map shows the geographic impact of Urška Kamenšek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urška Kamenšek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urška Kamenšek more than expected).

Fields of papers citing papers by Urška Kamenšek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urška Kamenšek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urška Kamenšek. The network helps show where Urška Kamenšek may publish in the future.

Co-authorship network of co-authors of Urška Kamenšek

This figure shows the co-authorship network connecting the top 25 collaborators of Urška Kamenšek. A scholar is included among the top collaborators of Urška Kamenšek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urška Kamenšek. Urška Kamenšek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 1
4 8
5 6
6 13
7 12
8 34
9 41
10 3
11 29
12 6
13 14
14 119
15 12
16 23
17 13
18 21
19 31
20 20

About Urška Kamenšek

Urška Kamenšek is a scholar working on Biotechnology, Immunology and Genetics, having authored 52 papers that have together received 841 indexed citations. Recurring topics across this work include Microbial Inactivation Methods (35 papers), Virus-based gene therapy research (12 papers) and Microfluidic and Bio-sensing Technologies (12 papers). The work is most often cited by research in Biotechnology (557 citations), Immunology (243 citations) and Biomedical Engineering (252 citations). Urška Kamenšek has collaborated with scholars based in Slovenia, Italy and United States. Frequent co-authors include Maja Čemažar, Gregor Serša, Simona Kranjc, Emanuela Signori, Špela Kos, Damijan Miklavčič, Guillermo Marshall, Justin Teissié, Urša Lampreht Tratar and Tanja Jesenko. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Controlled Release.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026